These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29044221)

  • 1. Downregulation of miR-16 via URGCP pathway contributes to glioma growth.
    Hong L; Qing O; Ji Z; Chengqu Z; Ying C; Hao C; Minhui X; Lunshan X
    Sci Rep; 2017 Oct; 7(1):13470. PubMed ID: 29044221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
    Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
    PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
    Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
    BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.
    Hui W; Yuntao L; Lun L; WenSheng L; ChaoFeng L; HaiYong H; Yueyang B
    PLoS One; 2013; 8(1):e54932. PubMed ID: 23383003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
    Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
    Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP.
    Yu G; Zhang T; Jing Y; Bao Q; Tang Q; Zhang Y
    Life Sci; 2017 Apr; 175():47-51. PubMed ID: 28315691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway.
    Cai J; Li R; Xu X; Zhang L; Wu S; Yang T; Fang L; Wu J; Zhu X; Li M; Huang Y
    Oncotarget; 2015 Nov; 6(34):36489-504. PubMed ID: 26429875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
    Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
    J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.
    Dodurga Y; Gundogdu G; Tekin V; Koc T; Satiroglu-Tufan NL; Bagci G; Kucukatay V
    Mol Biol Rep; 2014 Jul; 41(7):4595-9. PubMed ID: 24652203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
    Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
    Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells.
    Sun G; Shi L; Yan S; Wan Z; Jiang N; Fu L; Li M; Guo J
    Biomed Res Int; 2014; 2014():687826. PubMed ID: 24995320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.
    Song Y; Shao L; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Shen S; Chen J; Li Z; Liu Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):248. PubMed ID: 31186064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer.
    Tang Z; Fang Y; Du R
    Biochem Biophys Res Commun; 2019 Apr; 512(2):331-337. PubMed ID: 30885433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
    Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
    J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel oncogene URG4/URGCP and its role in cancer.
    Dodurga Y; Seçme M; Lale Şatıroğlu-Tufan N
    Gene; 2018 Aug; 668():12-17. PubMed ID: 29775749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of isocitrate dehydrogenase 1 induces glioma cell proliferation via nuclear factor-κB activation in a hypoxia-inducible factor 1-α dependent manner.
    Wang G; Sai K; Gong F; Yang Q; Chen F; Lin J
    Mol Med Rep; 2014 May; 9(5):1799-805. PubMed ID: 24626950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.
    Song L; Liu L; Wu Z; Li Y; Ying Z; Lin C; Wu J; Hu B; Cheng SY; Li M; Li J
    J Clin Invest; 2012 Oct; 122(10):3563-78. PubMed ID: 23006329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.